ISSN: 1307-5888 | E-ISSN: 2757-7392 | Contact
Volume: 5 Issue: 4 Year: 2024
Copyright Transfer Form Author Contribution Form ICMJE COI Form
Submit an Article

Volume: 2 Issue: 3 - 2021

Cover

1. Cover
Pages : I-I
Full Text PDF

Editorial Board

2. Editorial Board
Pages : II-IV
Full Text PDF

Contents

3. Contents
Pages : V-V
Full Text PDF

Editorial

4. New therapeutic players on the horizon: edible plant derived exosomes
Murat Kantarcıoğlu
DOI: 10.14744/hf.2021.2021.ed0002 PMCID: PMC9138940 Pages : 89-90
Full Text PDF

Research Articles

5. Are nucleos(t)ide analogs effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?
Gupse Adalı, Pınar Gökçen, Fatih Güzelbulut, Ayça Gökçen Değirmenci Saltürk, Nihat Buğra Ağaoğlu, Büşra Ünal, Levent Doğanay, Kamil Özdil
DOI: 10.14744/hf.2021.2021.0027 PMCID: PMC9138945 Pages : 91-96
Abstract Full Text PDF
6. Sustainability of diet based on moderate calorie restriction among obese patients with metabolic-associated fatty liver disease
Hakan Güveli, Tuğçe Özlü, Büşra Ersoy Taşar, Emre Batuhan Kenger, Eda Kaya
DOI: 10.14744/hf.2021.2021.0014 PMCID: PMC9138938 Pages : 97-101
Abstract Full Text PDF
7. The effect of transarterial chemoembolization therapy on survival in patients with non-resectable hepatocellular carcinoma: Single-center study results
Mehmet Kolu, Osman Dere, Süleyman Sönmez
DOI: 10.14744/hf.2021.2021.0029 PMCID: PMC9138947 Pages : 102-106
Abstract Full Text PDF
8. An appointment lead time of more than two weeks is significantly associated with not presenting for a liver biopsy procedure
Hasan Yılmaz
DOI: 10.14744/hf.2021.2021.0032 PMCID: PMC9138944 Pages : 107-111
Abstract Full Text PDF

Case Report

9. A novel insight into the pathophysiology of autoimmune hepatitis: An immune activator mutation in the FLT3 receptor
Muhammed Yuksel, Ayse Armutlu, Farinaz Nazmi, Serdar Ceylaner, Cigdem Arikan
DOI: 10.14744/hf.2021.2021.0010 PMCID: PMC9138941 Pages : 112-116
Abstract Full Text PDF
10. De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor
Harjot K. Bedi, Roberto Trasolini, Christopher F. Lowe, Trana Hussaini, Mark Bigham, Gordon Ritchie, Eric M. Yoshida
DOI: 10.14744/hf.2021.2021.0019 PMCID: PMC9138942 Pages : 117-119
Abstract Full Text PDF

Review Article

11. An overview of SARS-COV-2 related hepatic injury
Abdullah Tarık Aslan, Hatice Yasemin Balaban
DOI: 10.14744/hf.2021.2021.0020 PMCID: PMC9138946 J Pages : 122-127
Abstract Full Text PDF
12. The relationship between polyphenols and miRNAs: A novel therapeutic strategy for metabolic associated fatty liver diseas
Hatice Merve Bayram, Fatih Eren, Fatma Esra Güneş
DOI: 10.14744/hf.2021.2021.0037 Pages : 128-136
Abstract Full Text PDF

Letter to the Editor

13. Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome
Mubin Özercan, İrem Eser, Saba Kiremitçi, Bora Peynircioğlu, Selim Karayalçın, Ramazan İdilman
DOI: 10.14744/hf.2021.2021.0028 PMCID: PMC9138943 Pages : 120-121
Full Text PDF

Case Report.

14. Brucellosis as a rare cause of granulomatous hepatitis with hepatic and bone marrow granulomas: A case report
Kendal Yalçın, Elif Tuğba Tuncel, Feyzullah Uçmak, Remzi Beştaş
DOI: 10.14744/hf.2021.2021.0038 PMCID: PMC9138939 Pages : 137-140
Abstract Full Text PDF (Turkish)